单独检测PMS2和MSH6的免疫组化可替代用于筛查结直肠癌错配修复缺陷的四抗体组合检测。 - Suppr | 超能文献

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.

作者信息

Hicks Sian C, Ward Robyn L, Hawkins Nicholas J

出版信息

Pathology. 2011 Jan;43(1):84-5; author reply 85-6. doi: 10.1097/PAT.0b013e3283410b26.

DOI:10.1097/PAT.0b013e3283410b26

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.单独检测PMS2和MSH6的免疫组化可替代用于筛查结直肠癌错配修复缺陷的四抗体组合检测。

Pathology. 2011 Jan;43(1):84-5; author reply 85-6. doi: 10.1097/PAT.0b013e3283410b26.

2

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.免疫组化检测 PMS2 和 MSH6 可单独替代四抗体 panel 用于结直肠腺癌错配修复缺陷的筛选。

Pathology. 2010;42(5):409-13. doi: 10.3109/00313025.2010.493871.

3

Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.免疫组织化学作为检测遗传性非息肉病性结直肠癌综合征风险的结直肠癌患者的一线筛查方法：双抗体组合可能与四抗体组合具有同样的预测性。

Am J Surg Pathol. 2009 Nov;33(11):1639-45. doi: 10.1097/PAS.0b013e3181b15aa2.

4

Immunochemistry screening for Lynch syndrome in colorectal adenocarcinoma using an initial two antibody panel can replace a four antibody panel.使用最初的双抗体组合对结直肠癌进行林奇综合征的免疫化学筛查可替代四抗体组合。

N Z Med J. 2013 Sep 13;126(1382):70-7.

5

A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas.一种用于结直肠癌、皮肤皮脂腺肿瘤和妇科生殖道肿瘤的两抗体错配修复蛋白免疫组化筛选方法。

Mod Pathol. 2011 Jul;24(7):1004-14. doi: 10.1038/modpathol.2011.55. Epub 2011 Apr 15.

6

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.结直肠癌患者中林奇综合征筛查的可行性

J Clin Oncol. 2008 Dec 10;26(35):5783-8. doi: 10.1200/JCO.2008.17.5950. Epub 2008 Sep 22.

7

Clinical problem-solving. Spot diagnosis.临床问题解决。现场诊断。

N Engl J Med. 2014 Jun 5;370(23):2229-36. doi: 10.1056/NEJMcps1302661.

8

Interobserver variability in the evaluation of mismatch repair protein immunostaining.免疫组化错配修复蛋白染色评估中的观察者间变异性。

Hum Pathol. 2010 Oct;41(10):1387-96. doi: 10.1016/j.humpath.2010.03.003. Epub 2010 Jun 22.

9

Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.利用分子肿瘤特征对早发性结直肠癌错配修复基因检测进行优先级排序。

J Clin Oncol. 2005 Sep 20;23(27):6524-32. doi: 10.1200/JCO.2005.04.671. Epub 2005 Aug 22.

10

PMS2 involvement in patients suspected of Lynch syndrome.PMS2在疑似林奇综合征患者中的作用。

Genes Chromosomes Cancer. 2009 Apr;48(4):322-9. doi: 10.1002/gcc.20642.

引用本文的文献

1

Simplifying Mismatch Repair Deficiency Screening in Endometrial Adenocarcinoma: Immunohistochemistry with Two-Antibody Panel (PMS2 and MSH6).简化子宫内膜腺癌错配修复缺陷筛查：使用两抗体组合（PMS2 和 MSH6）的免疫组织化学法。

Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3667-3671. doi: 10.31557/APJCP.2024.25.10.3667.

2

Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature.免疫组化生物标志物作为卵巢癌分子分析的替代指标：文献综述

Diagnostics (Basel). 2021 Jan 29;11(2):199. doi: 10.3390/diagnostics11020199.

3

Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.林奇综合征相关肿瘤：组织病理学和免疫组织化学讨论。

Fam Cancer. 2013 Jun;12(2):241-60. doi: 10.1007/s10689-013-9612-4.